Also in the announcement made at the 46th DIA Annual Meeting in Washington, Phlexglobal, specialists in paper and electronic trial master file solutions, unveiled Aidan Nuttall PhD as US office president.
Heading up Phlexglobal, Inc. Aidan, the co-founder and president of Abingdon Life Sciences and former president of Chiltern International’s US operation, will be working to extend the company’s client base and promote its innovative electronic Trial Master File (eTMF) services including the unique PhlexEview solution.
Phlexglobal’s move to open a US operation follows a sustained period of growth in the UK and Europe, and increasing interest from current and potential US-based client companies. Aidan said: “Phlexglobal has successfully established itself in Europe with a portfolio of niche services and I’m looking forward to extending that to our US clients.
“I believe we have a real commercial advantage in today’s clinical research arena. We offer a range of cost-effective and flexible support solutions allowing us to quickly become an extension of our clients’ internal teams.”
The opening of the US office comes only months after Phlexglobal signed a landmark contract with global biopharmaceutical company UCB to implement a complete TMF management solution in the UK and US worth £12 million over the next five years.
Nicola Murgatroyd, chief executive officer of Phlexglobal, commented: “This has been a really exciting 12 months for us, having secured the ongoing contract with UCB and with our US client base steadily growing, the next logical step was to open a US office.
“I am delighted to have Aidan on board to lead our US operation. His industry experience and contacts will be invaluable to us in promoting and delivering our services to the US clinical research market.”
Phlexglobal offers a unique combination of clinical trial knowledge, document management skills, technical expertise, personnel recruitment and training to the pharmaceutical, biotechnology, medical device, CRO and healthcare industries. Its unique electronic Trial Master File (eTMF) solution, PhlexEview, is a quality controlled end-to-end process enabling the electronic searching and viewing of centralized TMF documentation from sponsors, subsidiaries, CROs and field-based personnel from anywhere in the world at any time.
With 17 of the top 20 global pharmaceutical companies as clients Phlexglobal is committed to achieving high levels of client satisfaction.
For further information about Phlexglobal and its services log onto the website at www.phlexglobal.com.
For further information, please contact:
Chrissie Walker BCS Public Relations Tel: +44 (0)115 9486901 or +44 (0)7809 656 217 Email: chrissie@bcspr.co.uk
PhlexEview is a registered trademark of Phlexglobal Ltd.
About Phlexglobal (www.phlexglobal.com)
Established in 1997 Phlexglobal delivers a specialist comprehensive service for all administrative aspects of the clinical trial process across the pharmaceutical, biotechnology, medical device and healthcare industries.
Phlexglobal offers a unique combination of clinical trial knowledge, document management skills, regulatory understanding and technical expertise to deliver clinical research support solutions to meet business needs.
Its unique PhlexEview service is an end-to-end TMF solution, which allows logical electronic searching and viewing of TMF documentation, once it has been prepared, scanned and indexed into the system. Preparing for archive, TMF QC checking and archive storage completes the management cycle.
